View in EDS

Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.

Saved in:
Bibliographic Details
Title: Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.
Authors: Guzi TJ; Merck Research Laboratory, Cambridge, Masachusetts, USA., Paruch K, Dwyer MP, Labroli M, Shanahan F, Davis N, Taricani L, Wiswell D, Seghezzi W, Penaflor E, Bhagwat B, Wang W, Gu D, Hsieh Y, Lee S, Liu M, Parry D
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2011 Apr; Vol. 10 (4), pp. 591-602. Date of Electronic Publication: 2011 Feb 14.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 21321066
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guzi+TJ%22">Guzi TJ</searchLink>; Merck Research Laboratory, Cambridge, Masachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Paruch+K%22">Paruch K</searchLink><br /><searchLink fieldCode="AU" term="%22Dwyer+MP%22">Dwyer MP</searchLink><br /><searchLink fieldCode="AU" term="%22Labroli+M%22">Labroli M</searchLink><br /><searchLink fieldCode="AU" term="%22Shanahan+F%22">Shanahan F</searchLink><br /><searchLink fieldCode="AU" term="%22Davis+N%22">Davis N</searchLink><br /><searchLink fieldCode="AU" term="%22Taricani+L%22">Taricani L</searchLink><br /><searchLink fieldCode="AU" term="%22Wiswell+D%22">Wiswell D</searchLink><br /><searchLink fieldCode="AU" term="%22Seghezzi+W%22">Seghezzi W</searchLink><br /><searchLink fieldCode="AU" term="%22Penaflor+E%22">Penaflor E</searchLink><br /><searchLink fieldCode="AU" term="%22Bhagwat+B%22">Bhagwat B</searchLink><br /><searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink><br /><searchLink fieldCode="AU" term="%22Gu+D%22">Gu D</searchLink><br /><searchLink fieldCode="AU" term="%22Hsieh+Y%22">Hsieh Y</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink><br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink><br /><searchLink fieldCode="AU" term="%22Parry+D%22">Parry D</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2011 Apr; Vol. 10 (4), pp. 591-602. <i>Date of Electronic Publication: </i>2011 Feb 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21321066
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-10-0928
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 591
    Titles:
      – TitleFull: Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guzi TJ
      – PersonEntity:
          Name:
            NameFull: Paruch K
      – PersonEntity:
          Name:
            NameFull: Dwyer MP
      – PersonEntity:
          Name:
            NameFull: Labroli M
      – PersonEntity:
          Name:
            NameFull: Shanahan F
      – PersonEntity:
          Name:
            NameFull: Davis N
      – PersonEntity:
          Name:
            NameFull: Taricani L
      – PersonEntity:
          Name:
            NameFull: Wiswell D
      – PersonEntity:
          Name:
            NameFull: Seghezzi W
      – PersonEntity:
          Name:
            NameFull: Penaflor E
      – PersonEntity:
          Name:
            NameFull: Bhagwat B
      – PersonEntity:
          Name:
            NameFull: Wang W
      – PersonEntity:
          Name:
            NameFull: Gu D
      – PersonEntity:
          Name:
            NameFull: Hsieh Y
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Parry D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2011 Apr
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1